Silver nanoparticles (AgNPs) have emerged as a potent antimicrobial agent capable of combating a wide range of bacteria, including both Gram-negative and Gram-positive strains, as well as multidrug-resistant strains. They are particularly effective due to their multiple and simultaneous mechanisms of action. When used in combination with conventional antibiotics, AgNPs have shown a synergistic effect, enhancing the efficacy against pathogenic bacteria such as Escherichia coli and Staphylococcus aureus.<br />The antibacterial properties of AgNPs are attributed to their ability to anchor to and penetrate bacterial cell walls. Once inside the cell, they can disrupt cellular processes by dephosphorylating key peptide substrates critical for cell viability and division. Additionally, the generation of free radicals from the surface of AgNPs is believed to contribute to their antibacterial action.<br />Silver nanoparticles are less reactive than silver ions, which makes them more suitable for medical applications. They have been incorporated into wound dressings, catheters, and various healthcare products to treat or prevent infections effectively. The size, shape, and concentration of AgNPs play a crucial role in determining their antimicrobial activities.<br />In summary, the role of silver nanoparticles as antibacterial agents is significant due to their ability to disrupt bacterial cells and enhance the effects of antibiotics, making them a valuable asset in the medical field for infection control and treatment.<br />